We showed that the expression of the major intracellular components of the NF-κΒ alternative pathway i.e. NF-κΒ2, RelB, NIK and Bcl3 are particularly deregulated in NSCLC. The gene discussed is RELB; the disease is non-small cell lung carcinoma.